UK markets closed

Cipher Pharmaceuticals Inc. (PHE.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
6.05+0.15 (+2.54%)
At close: 09:49PM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 142.26M
Enterprise value 105.43M
Trailing P/E 7.90
Forward P/E 13.87
PEG ratio (5-yr expected) N/A
Price/sales (ttm)7.60
Price/book (mrq)1.89
Enterprise value/revenue 4.98
Enterprise value/EBITDA 9.36

Trading information

Stock price history

Beta (5Y monthly) 1.04
52-week change 3168.18%
S&P500 52-week change 322.38%
52-week high 36.65
52-week low 32.16
50-day moving average 35.56
200-day moving average 33.97

Share statistics

Avg vol (3-month) 3272
Avg vol (10-day) 3240
Shares outstanding 524.11M
Implied shares outstanding 624.11M
Float 822.57M
% held by insiders 144.51%
% held by institutions 11.12%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 96.32%
Operating margin (ttm)48.15%

Management effectiveness

Return on assets (ttm)8.06%
Return on equity (ttm)28.19%

Income statement

Revenue (ttm)21.16M
Revenue per share (ttm)0.85
Quarterly revenue growth (yoy)0.20%
Gross profit (ttm)N/A
EBITDA 11.44M
Net income avi to common (ttm)20.38M
Diluted EPS (ttm)0.75
Quarterly earnings growth (yoy)-61.10%

Balance sheet

Total cash (mrq)39.83M
Total cash per share (mrq)1.66
Total debt (mrq)353k
Total debt/equity (mrq)0.44%
Current ratio (mrq)9.19
Book value per share (mrq)3.36

Cash flow statement

Operating cash flow (ttm)16M
Levered free cash flow (ttm)5.48M